Back to Search
Start Over
Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
- Source :
-
Nephron [Nephron] 2017; Vol. 135 (3), pp. 231-241. Date of Electronic Publication: 2016 Dec 20. - Publication Year :
- 2017
-
Abstract
- Background: Monocytic products, such as lipoprotein-associated phospholipase A2 (Lp-PLA2), may participate in the development of atherosclerosis. Heterogeneity of monocytes is widely acknowledged. Classical, intermediate, and non-classical subsets can be discerned. Recently, an inflammatory, pro-atherogenic monocyte population could be identified in hemodialysis patients. In this study, we investigated the expression of Lp-PLA2 on leucocytes and different monocyte subpopulations and their possible role in uremia, inflammation, and atherosclerosis.<br />Methods: Chronic kidney disease stage 5-D (CKD5-D; n = 57), healthy control subjects with hs-C-reactive protein (CRP) levels ≤1 mg/L (CO-N, n = 22) and a control group with inflammatory activation (CRP levels >1 mg/L, CO-I, n = 29) were enrolled in this cross-sectional observation. The CKD5-D cohort was dichotomized into patients with (A+) and without subclinical atherosclerosis (A-) by carotid artery ultrasound measurement. Lp-PLA2 activity was determined in plasma samples, Lp-PLA2 mRNA expression analysis in leucocytes, and sorted monocyte subsets. Effects of Lp-PLA2 overexpression were studied in classical vs. intermediate and non-classical subsets.<br />Results: The classical monocytes expressed the highest Lp-PLA2 mRNA levels as compared to other subpopulations. CKD5-D patients revealed significantly higher Lp-PLA2 transcripts, as well as higher Lp-PLA2 plasma activity as compared to healthy and "inflammatory" controls. In vitro data confirmed that uremia significantly contributes to Lp-PLA2 mRNA upregulation. Non-classical monocytes of A+ patients revealed significant higher Lp-PLA2 mRNA compared to A-.<br />Conclusion: Uremic environment but not inflammation per se increases plasma Lp-PLA2 activity and upregulates monocytic Lp-PLA2 mRNA expression. The highest Lp-PLA2 levels were found in the classical and not in the inflammatory subsets. Atherosclerosis also contributes to a subset-specific increase in Lp-PLA2 mRNA expression.<br /> (© 2016 S. Karger AG, Basel.)
- Subjects :
- Aged
Atherosclerosis blood
Case-Control Studies
Cross-Sectional Studies
Female
Humans
Inflammation Mediators blood
Leukocytes enzymology
Lipid Metabolism genetics
Male
Middle Aged
Monocytes classification
RNA, Messenger blood
RNA, Messenger genetics
Up-Regulation
Uremia blood
1-Alkyl-2-acetylglycerophosphocholine Esterase blood
1-Alkyl-2-acetylglycerophosphocholine Esterase genetics
Atherosclerosis enzymology
Atherosclerosis genetics
Monocytes enzymology
Uremia enzymology
Uremia genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2235-3186
- Volume :
- 135
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Nephron
- Publication Type :
- Academic Journal
- Accession number :
- 27992874
- Full Text :
- https://doi.org/10.1159/000454778